Remove novartis-actively-reviewing-relationships-chinese-contractors-amid-us-biosecurity-crackdown
article thumbnail

Novartis 'actively' reviewing relationships with Chinese contractors amid US biosecurity crackdown: CFO

Fierce Pharma

As the BIOSECURE Act threatens to upend relationships with Chinese contractors and western biopharma companies operating in the U.S., Novartis has elected not to adopt a “wait and see” attitude.

Biopharma 237